2026-10-16
During high-density microbial fermentation and strain screening, the accumulation of surface-active agents (such as proteins and peptides) combined with aggressive aeration and high-speed agitation frequently generates excessive foam. If left unmanaged, foam can rise to the top of the vessel, leading to foam overflow, exhaust filter blockages, volume loss, and severe contamination risks.
Traditional anti-foaming approaches rely heavily on manual inspection or continuous, fixed-rate chemical dosing. However, over-dosing chemical antifoam agents alters broth surface tension, reduces the volumetric mass transfer coefficient ($K_L a$), and may exert cellular toxicity while complicating downstream purification. Consequently, evaluating a benchtop bioreactor's capability to deliver demand-based dosing—injecting antifoam only when foam is present—is vital during equipment selection.
Modern automated bioreactors integrate conductive sensor hardware with control software to deliver responsive closed-loop antifoam management:
When selecting laboratory bioreactors for high-density fermentation and upstream bioprocess development, process engineers should review the following evaluation criteria:
Send your inquiry directly to us